Wang Q, Wipf P
J Med Chem. 2022; 66(1):122-139.
PMID: 36538005
PMC: 10228507.
DOI: 10.1021/acs.jmedchem.2c01599.
Bossuyt J, Borst J, Verberckmoes M, Bailey L, Bers D, Hegyi B
J Am Heart Assoc. 2022; 11(19):e027573.
PMID: 36172952
PMC: 9673734.
DOI: 10.1161/JAHA.122.027573.
Lv D, Chen H, Feng Y, Cui B, Kang Y, Zhang P
Front Oncol. 2021; 11:680221.
PMID: 34249722
PMC: 8263921.
DOI: 10.3389/fonc.2021.680221.
Zhang X, Connelly J, Chao Y, Wang Q
Biomolecules. 2021; 11(3).
PMID: 33807058
PMC: 8005150.
DOI: 10.3390/biom11030483.
Liu Y, Song H, Zhou Y, Ma X, Xu J, Yu Z
J Cancer. 2021; 12(3):735-739.
PMID: 33403031
PMC: 7778554.
DOI: 10.7150/jca.50899.
Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1).
Feng J, Lee P, Alaoui M, Barrett K, Castanedo G, Godemann R
ACS Med Chem Lett. 2019; 10(9):1260-1265.
PMID: 31531194
PMC: 6746091.
DOI: 10.1021/acsmedchemlett.8b00658.
Inflammation leads through PGE/EP signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes.
Toth A, Schell R, Levay M, Vettel C, Theis P, Haslinger C
EMBO Mol Med. 2018; 10(7).
PMID: 29907596
PMC: 6034133.
DOI: 10.15252/emmm.201708536.
Protein kinase D2: a versatile player in cancer biology.
Azoitei N, Cobbaut M, Becher A, Van Lint J, Seufferlein T
Oncogene. 2017; 37(10):1263-1278.
PMID: 29259300
DOI: 10.1038/s41388-017-0052-8.
Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening.
Nalini , Chadha N, Bahia M, Kaur M, Bahadur R, Silakari O
Mol Divers. 2017; 22(1):47-56.
PMID: 29058231
DOI: 10.1007/s11030-017-9785-0.
Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-]pyrimidine analogues.
Verschueren K, Cobbaut M, Demaerel J, Saadah L, Voet A, Van Lint J
Medchemcomm. 2017; 8(3):640-646.
PMID: 28890776
PMC: 5567267.
DOI: 10.1039/c6md00675b.
Protein kinase D signaling in cancer: A friend or foe?.
Roy A, Ye J, Deng F, Wang Q
Biochim Biophys Acta Rev Cancer. 2017; 1868(1):283-294.
PMID: 28577984
PMC: 5548606.
DOI: 10.1016/j.bbcan.2017.05.008.
Role of Phosphorylated HDAC4 in Stroke-Induced Angiogenesis.
Liu J, Zhou X, Li Q, Zhou S, Hu B, Hu G
Biomed Res Int. 2017; 2017:2957538.
PMID: 28127553
PMC: 5239970.
DOI: 10.1155/2017/2957538.
A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY.
Aicart-Ramos C, He S, Land M, Rubin C
J Biol Chem. 2016; 291(45):23516-23531.
PMID: 27662904
PMC: 5095407.
DOI: 10.1074/jbc.M116.735399.
Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle.
Lemon D, Harrison B, Horn T, Stratton M, Ferguson B, Wempe M
FEBS Lett. 2015; 589(10):1080-8.
PMID: 25816750
PMC: 4410688.
DOI: 10.1016/j.febslet.2015.03.017.
SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Tandon M, Salamoun J, Carder E, Farber E, Xu S, Deng F
PLoS One. 2015; 10(3):e0119346.
PMID: 25747583
PMC: 4352033.
DOI: 10.1371/journal.pone.0119346.
Histone deacetylase signaling in cardioprotection.
Lehmann L, Worst B, Stanmore D, Backs J
Cell Mol Life Sci. 2013; 71(9):1673-90.
PMID: 24310814
PMC: 3983897.
DOI: 10.1007/s00018-013-1516-9.
Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.
Stathopoulou K, Cuello F, Candasamy A, Kemp E, Ehler E, Haworth R
Biochem J. 2013; 457(3):451-61.
PMID: 24219103
PMC: 3927927.
DOI: 10.1042/BJ20131026.
New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
Tandon M, Johnson J, Li Z, Xu S, Wipf P, Wang Q
PLoS One. 2013; 8(9):e75601.
PMID: 24086585
PMC: 3781056.
DOI: 10.1371/journal.pone.0075601.
A targeted library screen reveals a new inhibitor scaffold for protein kinase D.
Tandon M, Wang L, Xu Q, Xie X, Wipf P, Wang Q
PLoS One. 2012; 7(9):e44653.
PMID: 23028574
PMC: 3445516.
DOI: 10.1371/journal.pone.0044653.
Protein kinase D isoforms are dispensable for integrin-mediated lymphocyte adhesion and homing to lymphoid tissues.
Matthews S, Lek H, Morrison V, MacKenzie M, Zarrouk M, Cantrell D
Eur J Immunol. 2012; 42(5):1316-26.
PMID: 22311617
PMC: 3437483.
DOI: 10.1002/eji.201142004.